Cowen and Company Reiterates Buy Rating for Trupanion Inc (TRUP)

Trupanion Inc (NYSE:TRUP)‘s stock had its “buy” rating reaffirmed by analysts at Cowen and Company in a research note issued on Friday. They presently have a $19.00 target price on the financial services provider’s stock. Cowen and Company’s target price suggests a potential downside of 16.26% from the company’s previous close.

A number of other research firms also recently issued reports on TRUP. ValuEngine raised Trupanion from a “sell” rating to a “hold” rating in a research report on Friday, June 2nd. Northland Securities started coverage on Trupanion in a research report on Friday, May 26th. They set an “outperform” rating and a $22.75 price target on the stock. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and six have issued a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus target price of $19.14.

Trupanion (NYSE TRUP) opened at 22.69 on Friday. Trupanion has a 12 month low of $13.71 and a 12 month high of $23.89. The firm’s 50-day moving average price is $19.88 and its 200 day moving average price is $16.54. The stock’s market cap is $675.25 million.

TRADEMARK VIOLATION NOTICE: “Cowen and Company Reiterates Buy Rating for Trupanion Inc (TRUP)” was reported by Sports Perspectives and is the sole property of of Sports Perspectives. If you are viewing this news story on another website, it was stolen and reposted in violation of US & international copyright and trademark legislation. The legal version of this news story can be accessed at https://sportsperspectives.com/2017/07/18/cowen-and-company-reiterates-buy-rating-for-trupanion-inc-trup.html.

In related news, insider Darryl Rawlings sold 3,500 shares of the company’s stock in a transaction on Thursday, April 20th. The stock was sold at an average price of $14.86, for a total transaction of $52,010.00. Following the completion of the sale, the insider now directly owns 1,481,005 shares in the company, valued at approximately $22,007,734.30. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, major shareholder General Partner Ll Maveron III sold 6,083 shares of the company’s stock in a transaction on Monday, May 15th. The stock was sold at an average price of $16.89, for a total value of $102,741.87. The disclosure for this sale can be found here. Insiders have sold a total of 23,583 shares of company stock valued at $440,142 over the last 90 days.

Several large investors have recently modified their holdings of the company. American International Group Inc. boosted its stake in Trupanion by 7.1% in the first quarter. American International Group Inc. now owns 8,864 shares of the financial services provider’s stock worth $126,000 after buying an additional 588 shares during the period. Dynamic Technology Lab Private Ltd acquired a new stake in Trupanion during the first quarter worth approximately $194,000. Bank of Montreal Can boosted its stake in Trupanion by 309.2% in the second quarter. Bank of Montreal Can now owns 9,044 shares of the financial services provider’s stock worth $201,000 after buying an additional 6,834 shares during the period. Alliancebernstein L.P. boosted its stake in Trupanion by 1.2% in the first quarter. Alliancebernstein L.P. now owns 16,700 shares of the financial services provider’s stock worth $237,000 after buying an additional 200 shares during the period. Finally, AQR Capital Management LLC boosted its stake in Trupanion by 0.3% in the fourth quarter. AQR Capital Management LLC now owns 22,264 shares of the financial services provider’s stock worth $346,000 after buying an additional 73 shares during the period.

About Trupanion

Trupanion, Inc provides medical insurance plans for cats and dogs throughout the United States, Canada and Puerto Rico. The Company operates in two business segments: subscription business and other business. The subscription business segment includes monthly subscriptions for its medical plan, which are marketed to consumers.

Analyst Recommendations for Trupanion (NYSE:TRUP)

Receive News & Ratings for Trupanion Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply